Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen N.V.    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
Delayed Quote. Delayed Nyse - 10/26 04:10:00 pm
49.26 USD   -1.10%
10/23QIAGEN NV : Independant Research remains a Sell rating
MD
10/14QIAGEN NV : Kepler Cheuvreux maintains a Buy rating
MD
10/13QIAGEN NV : Jefferies remains Neutral
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Most relevant news about QIAGEN N.V.
10/23QIAGEN NV : Independant Research remains a Sell rating
MD
10/14QIAGEN NV : Kepler Cheuvreux maintains a Buy rating
MD
10/13QIAGEN NV : Jefferies remains Neutral
MD
10/13QIAGEN N : reports strong preliminary results for third quarter of 2020
BU
10/13QIAGEN N.V. : QIAGEN reports strong preliminary results for third quarter of 202..
EQ
10/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
10/05QIAGEN : to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies..
BU
09/18QIAGEN NV : Warburg Research reiterates its Neutral rating
MD
09/17QIAGEN N : fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR..
BU
09/15QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/11QIAGEN NV : Deutsche Bank remains its Buy rating
MD
09/09QIAGEN NV : Kepler Cheuvreux reiterates its Neutral rating
MD
More most relevant news
All news about QIAGEN N.V.
10/23QIAGEN NV : Independant Research remains a Sell rating
MD
10/14QIAGEN NV : Kepler Cheuvreux maintains a Buy rating
MD
10/13QIAGEN NV : Jefferies remains Neutral
MD
10/13QIAGEN N : reports strong preliminary results for third quarter of 2020
BU
10/13QIAGEN N.V. : QIAGEN reports strong preliminary results for third quarter of 202..
EQ
10/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
10/05QIAGEN : to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies..
BU
09/18QIAGEN NV : Warburg Research reiterates its Neutral rating
MD
09/17QIAGEN N : fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR..
BU
09/15QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
More news
News in other languages on QIAGEN N.V.
10/23QIAGEN NV : Independant Research toujours négatif
10/23Independent hebt Ziel für Qiagen auf 36 Euro - 'Verkaufen'
10/19INDEX-MONITOR: Potenzielle Gewinner einer Dax-Aufstockung
10/14QIAGEN NV : Kepler Cheuvreux favorable sur le dossier
10/13Aktien Frankfurt Schluss: Verluste - Anleger werden wieder vorsichtiger
10/13Aktien Frankfurt Schluss: Verluste - Anleger werden wieder vorsichtiger
10/13QIAGEN NV : Jefferies est neutre
10/13Jefferies belässt Qiagen auf 'Hold' - Ziel 46 Euro
10/13AKTIE IM FOKUS : Gewinnmitnahmen nach guten Quartalszahlen belasten Qiagen
10/13Qiagen setzt dank Corona-Tests mehr um als erwartet - Aktie verliert
Analyst Recommendations on QIAGEN N.V.
10/23QIAGEN NV : Independant Research remains a Sell rating
MD
10/14QIAGEN NV : Kepler Cheuvreux maintains a Buy rating
MD
10/13QIAGEN NV : Jefferies remains Neutral
MD
09/18QIAGEN NV : Warburg Research reiterates its Neutral rating
MD
09/15QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
More recommendations
Press releases
10/13QIAGEN N : reports strong preliminary results for third quarter of 2020
BU
10/13QIAGEN N.V. : QIAGEN reports strong preliminary results for third quarter of 202..
EQ
10/09QIAGEN N.V. : Release according to Article 40, Section 1 of the WpHG [the German..
EQ
10/05QIAGEN : to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies..
BU
09/17QIAGEN N : fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR..
BU
More press releases
Upcoming event on QIAGEN N.V.